Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)
Status:
Unknown status
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
An randomized trial of two maintenance doses of Acthar Gel for patients with chronic
pulmonary sarcoidosis. Patients will be observed for 24 weeks of treatment.